… of various viruses including the novel severe acute respiratory syndrome coronavirus 2. …
exosomes and respiratory viruses, describe potential exosome therapeutics for viral infections, …

… 2 virus characterized by a severe acute respiratory impairment … such as exosomes (MSC-Exo)
considerably improved lung … therapeutic application of exosomes in SARS-CoV-2 virus …

… of exosomes in chronic lung allograft rejection in patients suffering from respiratory viral
infections from 17 viruses, … and increased lung SAgs were detected in isolated exosomes from …

… the use of exosomes in various respiratory infectious diseases … new ideas for the treatment
of new coronavirus infections. … that exosomes may have a therapeutic effect on COVID-19. …

… Exosomes derived from respiratory syncytial virus–infected cells were able to activate an
innate immune response by inducing cytokine and chemokine release from human monocytes …

… These effects have paved the way towards the therapeutic use of this novel … acute lung
disorders, MSC-derived exosomes were also found to be responsible for direct inhibition of viral …

… , which showed that MSC exosomes could be a potent therapeutic candidate for treating …
is equivalent to many viruses and results in complications such as ARDS and lung damage, …

… system targeting lung macrophages using serum-derived EXOs. We also demonstrated
an effective approach to treating inflammatory lung responses using therapeutic siRNAs or …

… acute lung injury (ALI) induced by the influenza A (H5N1) virus… UC-MSC exosomes have
some therapeutic effects and only … MSCs at the early stage of H7N9 infection, while the other six …

… respiratory tract infections in children. In this study, we characterized exosomes released from
RSV-infected lung … to develop new therapeutic approaches. In this study, we characterized …